Award

Espenshade’s work called ‘brilliantly conceived and flawlessly executed’

He won ASBMB's Avanti Young Investigator Award
Geoff Hunt
February 23, 2012

The American Society for Biochemistry and Molecular Biology has named Peter Espenshade, associate professor of cell biology at Johns Hopkins University, the winner of the society’s Avanti Young Investigator Award in Lipid Research.

awards_avanti_epenshade

Peter Espenshade

 

About the award
 

The Avanti Young Investigator Award in Lipid Research, established by ASBMB’s Lipid Research Division, recognizes outstanding research contributions in the area of lipids by young investigators with no more than 15 years of experience since receiving their degrees (Ph.D. or M.D.). The award consists of a plaque, $2,000, and transportation and expenses to present a lecture at the 2012 ASBMB annual meeting.

“It is an honor to receive the 2012 ASBMB Avanti Young Investigator Award and to have the hard work of the students and postdocs in my lab acknowledged,” said Espenshade in response to receiving the award in recognition of his work investigating how cells sense and respond to changes in the supply of essential molecules.

According to Peter Devreotes from Johns Hopkins University, the implications of Espenshade’s work are “critical to research into the nature and prevention of cardiovascular disease and stroke.” Moreover, his multifaceted research on how cells regulate both oxygen levels and production of cholesterol “for the first time united the fields of sterol synthesis and oxygen regulation,” said Nobel laureate Michael Brown, with whom Espenshade trained as a postdoctoral fellow. “His work is original, brilliantly conceived and flawlessly executed.”

Randy Hampton, professor of biology at the University of California, San Diego, agreed. “Espenshade has an incredible sense of where to look to find really fascinating and important things – and what to do to turn them into great stories and lines of inquiry.”

After graduating summa cum laude from Princeton University, Espenshade completed his Ph.D. in biology at the Massachusetts Institute of Technology in 1997. During his postdoctoral fellowship with Brown and fellow Nobel laureate Joseph Goldstein at the University of Texas Southwestern Medical Center at Dallas, Espenshade used mammalian cell systems to decipher pathways involved in environmental sensing, in particular focusing on cholesterol homeostasis.

In 2003, he moved to his current position at Johns Hopkins, where he expanded his research to incorporate the fission yeast Schizosaccharomyces pombe as a model system. Espenshade’s ability to “exploit the strengths of both fungal and mammalian model systems to make paradigm-shifting discoveries” led Devreotes to nominate Espenshade for the award. “I have no doubt that his future achievements will be even more prominent.”

Espenshade will receive his award during the Experimental Biology 2012 conference in San Diego, where he will deliver an award lecture. The presentation will take place at 9:55 a.m. April 23 in the San Diego Convention Center.

 

 

Geoff Hunt

Geoff Hunt is the ASBMB's former outreach manager. 

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

A career supporting research innovation
Jobs

A career supporting research innovation

December 04, 2020

Careers columnist Martina G. Efeyini talked to Kerisha Bowen about how she transitioned from organic chemist to patent agent.

A life devoted to teaching and research
Research Spotlight

A life devoted to teaching and research

December 03, 2020

Inspired by her aunt, a college professor, Karlett Parra’s scientific journey has taken her from Venezuela to New Mexico

The Death Project
Books

The Death Project

December 02, 2020

In an excerpt from his upcoming book, a Nobel laureate recounts the unexpected challenges of determining a receptor’s structure.

James Siedow (1947–2020)
Retrospective

James Siedow (1947–2020)

November 30, 2020

The former Duke University administrator and plant researcher is remembered for his leadership, discoveries and kindness.

Targeting two-faced nuclear receptors to fight cancer
News

Targeting two-faced nuclear receptors to fight cancer

November 24, 2020

For small-molecule cancer drugs, context is everything. Drugs that ameliorate cancer in some tissues may increase the cancer risk in others. Researcher Stephen Safe has turned this challenge into an opportunity.

Gerald S. Berenson (1922–2018)
Retrospective

Gerald S. Berenson (1922–2018)

November 23, 2020

A physician–scientist who devoted more than six decades to understanding the causes of cardiovascular disease, Berenson was one of the earliest members of the American Society for Biochemistry and Molecular Biology.